Spanish consensus on the use of natalizumab (Tysabri®) – 2011

Spanish consensus on the use of natalizumab (Tysabri®) – 2011

Introduction: Natalizumab is very effective at reducing relapses and delaying disease progression in patients with relapsing-remitting multiple sclerosis (RRMS). However, treatment has also been associated with a risk of progressive multifocal leukoencephalopathy (PML). The aim of this article is to...

Full description

Bibliographic Details
Main Authors: O. Fernández, J.A. García-Merino, R. Arroyo, J.C. Álvarez-Cermeño, T. Arbizu, G. Izquierdo, A. Saiz, J. Olascoaga, A. Rodríguez-Antigüedad, J.M. Prieto, C. Oreja-Guevara, M.A. Hernández, X. Montalbán
Format: Article
Language:English
Published: Elsevier España 2012-09-01
Series:Neurología (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580812001320

Internet

http://www.sciencedirect.com/science/article/pii/S2173580812001320

Similar Items